NasdaqGS - Delayed Quote USD
Cytokinetics, Incorporated (CYTK)
34.38
+1.18
+(3.55%)
At close: June 13 at 4:00:02 PM EDT
34.36
-0.02
(-0.06%)
After hours: June 13 at 7:25:02 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 366,247 | 39 |
| Sales | 261,347 | 40 |
| Net Shares Purchased (Sold) | 104,900 | 79 |
| Total Insider Shares Held | 895.7k | -- |
| % Net Shares Purchased (Sold) | 13.30% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| CALLOS ANDREW Officer | Sale at price 32.04 per share. | Direct | 277,434 | Jun 5, 2025 |
| KAYE EDWARD M Director | Sale at price 32.10 per share. | Direct | 116,716 | Jun 5, 2025 |
| MALIK FADY IBRAHAM Officer | Conversion of Exercise of derivative security at price 10.60 per share. | Direct | 21,200 | Jun 3, 2025 |
| MALIK FADY IBRAHAM Officer | Sale at price 31.88 per share. | Direct | 63,760 | Jun 3, 2025 |
| BLUM ROBERT I Chief Executive Officer | Sale at price 31.22 per share. | Direct | 156,100 | Jun 2, 2025 |
| MALIK FADY IBRAHAM Officer | Conversion of Exercise of derivative security at price 10.60 per share. | Direct | 21,200 | May 20, 2025 |
| MALIK FADY IBRAHAM Officer | Sale at price 31.98 per share. | Direct | 63,960 | May 20, 2025 |
| BLUM ROBERT I Chief Executive Officer | Sale at price 30.93 per share. | Direct | 154,650 | May 16, 2025 |
| BHANJI MUNA Director | Sale at price 29.73 per share. | Direct | 43,227 | May 15, 2025 |
| KAYE EDWARD M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 14, 2025 |
| LANDRY ROBERT E Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 14, 2025 |
| WYSENSKI NANCY J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 14, 2025 |
| BHANJI MUNA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 14, 2025 |
| HARRINGTON ROBERT ARTHUR M.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 14, 2025 |
| WIERENGA WENDELL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 14, 2025 |
| HENDERSON JOHN TANNAHILL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 14, 2025 |
| PARSHALL B LYNNE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 14, 2025 |
| MALIK FADY IBRAHAM Officer | Conversion of Exercise of derivative security at price 10.60 per share. | Direct | 21,200 | May 6, 2025 |
| MALIK FADY IBRAHAM Officer | Sale at price 35.01 per share. | Direct | 70,020 | May 6, 2025 |
| CALLOS ANDREW Officer | Sale at price 36.68 per share. | Direct | 146,793 | May 5, 2025 |
| BLUM ROBERT I Chief Executive Officer | Sale at price 40.96 per share. | Direct | 204,800 | Apr 29, 2025 |
| MALIK FADY IBRAHAM Officer | Conversion of Exercise of derivative security at price 10.60 per share. | Direct | 21,200 | Apr 22, 2025 |
| MALIK FADY IBRAHAM Officer | Sale at price 38.11 per share. | Direct | 76,220 | Apr 22, 2025 |
| WIERENGA WENDELL Director | Conversion of Exercise of derivative security at price 6.21 per share. | Direct | 124,200 | Apr 21, 2025 |
| WIERENGA WENDELL Director | Sale at price 38.46 per share. | Direct | 769,200 | Apr 21, 2025 |
| HENDERSON JOHN TANNAHILL Director | Conversion of Exercise of derivative security at price 6.21 per share. | Direct | 124,200 | Apr 15, 2025 |
| KAYE EDWARD M Director | Stock Award(Grant) at price 38.56 per share. | Direct | 12,493 | Apr 15, 2025 |
| WYSENSKI NANCY J Director | Stock Award(Grant) at price 38.56 per share. | Direct | 6,247 | Apr 15, 2025 |
| HARRINGTON ROBERT ARTHUR M.D. Director | Stock Award(Grant) at price 38.56 per share. | Direct | 12,493 | Apr 15, 2025 |
| WIERENGA WENDELL Director | Stock Award(Grant) at price 38.56 per share. | Direct | 6,247 | Apr 15, 2025 |
| HENDERSON JOHN TANNAHILL Director | Stock Award(Grant) at price 38.56 per share. | Direct | 21,247 | Apr 15, 2025 |
| HENDERSON JOHN TANNAHILL Director | Sale at price 38.66 per share. | Direct | 123,325 | Apr 15, 2025 |
| BLUM ROBERT I Chief Executive Officer | Sale at price 36.77 per share. | Direct | 183,850 | Apr 10, 2025 |
| MALIK FADY IBRAHAM Officer | Conversion of Exercise of derivative security at price 10.60 per share. | Direct | 21,200 | Apr 8, 2025 |
| MALIK FADY IBRAHAM Officer | Sale at price 36.18 per share. | Direct | 72,360 | Apr 8, 2025 |
| CALLOS ANDREW Officer | Sale at price 35.78 per share. | Direct | 103,261 | Apr 7, 2025 |
| HARRINGTON ROBERT ARTHUR M.D. Director | Sale at price 39.43 per share. | Direct | 17,744 | Apr 3, 2025 |
| BLUM ROBERT I Chief Executive Officer | Sale at price 40.75 per share. | Direct | 611,250 | Mar 31, 2025 |
| MALIK FADY IBRAHAM Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Mar 19, 2025 |
| MALIK FADY IBRAHAM Officer | Conversion of Exercise of derivative security at price 10.60 per share. | Direct | 21,200 | Mar 18, 2025 |
| MALIK FADY IBRAHAM Officer | Sale at price 43.58 per share. | Direct | 87,160 | Mar 18, 2025 |
| CALLOS ANDREW Officer | Conversion of Exercise of derivative security at price 23.26 per share. | Direct | 486,134 | Mar 17, 2025 |
| CALLOS ANDREW Officer | Sale at price 45.14 per share. | Direct | 943,426 | Mar 17, 2025 |
| CALLOS ANDREW Officer | Sale at price 44.38 per share. | Direct | 123,154 | Mar 17, 2025 |
| BLUM ROBERT I Chief Executive Officer | Sale at price 44.65 per share. | Direct | 1,116,250 | Mar 17, 2025 |
| BLUM ROBERT I Chief Executive Officer | Sale at price 44.38 per share. | Direct | 561,318 | Mar 17, 2025 |
| MALIK FADY IBRAHAM Officer | Sale at price 44.38 per share. | Direct | 194,784 | Mar 17, 2025 |
| CALLOS ANDREW Officer | Conversion of Exercise of derivative security at price 23.26 per share. | Direct | 2,326 | Mar 14, 2025 |
| MALIK FADY IBRAHAM Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2025 |
| LEE SUNG Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2025 |
Related Tickers
BBIO BridgeBio Pharma, Inc.
39.78
+0.33%
AKRO Akero Therapeutics, Inc.
55.62
+3.85%
PCVX Vaxcyte, Inc.
34.56
+0.29%
RARE Ultragenyx Pharmaceutical Inc.
37.49
-4.58%
MLTX MoonLake Immunotherapeutics
44.21
+0.43%
SRRK Scholar Rock Holding Corporation
32.45
-2.61%
MDGL Madrigal Pharmaceuticals, Inc.
295.57
-0.55%
ASMB Assembly Biosciences, Inc.
16.85
-1.46%
KROS Keros Therapeutics, Inc.
13.56
-0.59%
APLS Apellis Pharmaceuticals, Inc.
18.83
-2.23%